Breaking News, Financial News

Financial Report: Patheon

Terminated supply pact impact results

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon   1Q Revenues: $153.9 million (-12%) 1Q Loss: $19.4 million (earnings were $3.5 million 1Q11) Comments: Commercial manufacturing revenues were $122.8 million (-17%), impacted by a terminated $32.9 million manufacturing supply agreement. Pharmaceutical Development Services were $31.1 million (+15%), due to higher development activities from new contracts across most sites....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters